2,5-Dibromo-4-methylimidazole

Catalog No.: 
ACUYKM901
CAS No.: 
219814-29-6
Molecular Formula: 
C4H4Br2N2
Molecular Weight: 
239.90
2,5-Dibromo-4-methylimidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$111.00In stockInquiry
100g97%$334.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-Dibromo-4-methylimidazole
IUPAC Name2,4-dibromo-5-methyl-1H-imidazole
MDL No.MFCD02179519
Molecular FormulaC4H4Br2N2
Molecular Weight239.90
SMILESCC1=C(N=C([NH]1)Br)Br
InChI KeyRWHYUTSGEJYTMQ-UHFFFAOYSA-N
Synonym2,5-Dibromo-4-methylimidazole | 219814-29-6 | 2,4-Dibromo-5-methyl-1H-imidazole | 2,5-dibromo-4-methyl-1H-imidazole | C4H4Br2N2 | MFCD02179519 | 2,4-dibromo-5-methylimidazole | SCHEMBL3025834 | DTXSID10347074 | AMY12164 | CS-D1567 | Imidazole, 2,4-dibromo-5-methyl- | MFCD1808374
CAS No.219814-29-6
PubChem CID617665

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACUYKM901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWEOL817 route compound structure diagram
    ACWEOL817928113-28-4In Stock
  2. Then
  3. ACUYKM901 route product structure diagram
    ACUYKM901219814-29-6In Stock
Inquiry

2. ACUYKM901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUYKM901 route compound structure diagram
    ACUYKM901219814-29-6In Stock
  4. Then
  5. ACUYKM901 route product structure diagram
    ACUYKM901219814-29-6In Stock
Inquiry

3. ACUYKM901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUYKM901 route product structure diagram
    ACUYKM901219814-29-6In Stock
Inquiry

Comments (0)